Kitakami Caroline Shizue, Tiguman Gustavo Magno Baldin, Vieira Marcio Eduardo Bergamini, Aguiar Patricia Melo
Department of Pharmacy, Faculty of Pharmaceutical Sciences, University of São Paulo, Av. Prof. Lineu Prestes, 580 - Conj. das Quimicas - Bloco 13 - Cidade Universitaria Butanta, São Paulo, Brazil.
Faculty of Pharmaceutical Sciences, State University of Campinas, Campinas, Brazil.
J Immigr Minor Health. 2025 Feb;27(1):74-84. doi: 10.1007/s10903-024-01635-0. Epub 2024 Oct 3.
To analyze stigma related to depression, beliefs about psychotropics, and associated factors in a population of Japanese ancestry in Brazil. This cross-sectional study was conducted between March and June, 2022. Beliefs about psychotropics (BMQ-specific) and depression-related stigma (The Stigma Scale) were collected through an online questionnaire. Multiple linear regression analysis was performed to identify the factors associated with these dependent variables. Ninety-three respondents of Japanese ancestry completed the questionnaire. Participants were more focused on the necessity of the prescribed psychotropics than on possible adverse effects. Married individuals (β=-4.68 [95%CI -8.74, -0.63]; p = 0.024) were less concerned with their psychotropics than single individuals, while those undergoing treatment for longer years (β = 6.23 [95%CI 1.35, 11.11]; p = 0.013) perceive a greater necessity for treatment than those who started it recently. In addition, older individuals perceived less necessity for treatment (β=-5.83 [95%CI -10.76, -0.90]; p = 0.021) than younger individuals. Unemployed people (β = 12.09 [95%CI 0.47, 23.70]; p = 0.042) perceived more depression-related stigma than those employed. Aspects of Japanese cultural heritage related to depression and its treatment are still prevalent among people of Japanese ancestry in Brazil. Factors such as age, treatment duration, and marital status affects the perception of beliefs about psychotropics, whereas occupation affects the perception of stigma.
分析巴西日裔人群中与抑郁症相关的耻辱感、对精神药物的看法及相关因素。这项横断面研究于2022年3月至6月进行。通过在线问卷收集对精神药物的看法（特定于BMQ）和与抑郁症相关的耻辱感（耻辱感量表）。进行多元线性回归分析以确定与这些因变量相关的因素。93名日裔受访者完成了问卷。参与者更关注处方精神药物的必要性而非可能的不良反应。已婚个体（β=-4.68 [95%CI -8.74, -0.63]；p = 0.024）比单身个体对精神药物的关注更少，而接受治疗时间更长的个体（β = 6.23 [95%CI 1.35, 11.11]；p = 0.013）比近期开始治疗的个体更认为有治疗的必要性。此外，年长者（β=-5.83 [95%CI -10.76, -0.90]；p = 0.021）比年轻者更不认为有治疗的必要性。失业者（β = 12.09 [95%CI 0.47, 23.70]；p = 0.
